Cite
HARVARD Citation
Atsukawa, M. et al. (2017). Efficacy and safety of ombitasvir/paritaprevir/ritonavir in dialysis patients with genotype 1b chronic hepatitis C. Hepatology research. 47 (13), pp. 1429-1437. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Atsukawa, M. et al. (2017). Efficacy and safety of ombitasvir/paritaprevir/ritonavir in dialysis patients with genotype 1b chronic hepatitis C. Hepatology research. 47 (13), pp. 1429-1437. [Online].